287 related articles for article (PubMed ID: 21704169)
1. Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems.
Pontes DS; de Azevedo MS; Chatel JM; Langella P; Azevedo V; Miyoshi A
Protein Expr Purif; 2011 Oct; 79(2):165-75. PubMed ID: 21704169
[TBL] [Abstract][Full Text] [Related]
2. Heterologous protein production and delivery systems for Lactococcus lactis.
Nouaille S; Ribeiro LA; Miyoshi A; Pontes D; Le Loir Y; Oliveira SC; Langella P; Azevedo V
Genet Mol Res; 2003 Mar; 2(1):102-11. PubMed ID: 12917806
[TBL] [Abstract][Full Text] [Related]
3. [Progress on lactococcus lactis expressing heterologous antigens as live mucosal vaccines].
Shi D; Song Y; Li YJ
Wei Sheng Wu Xue Bao; 2006 Aug; 46(4):680-3. PubMed ID: 17037080
[TBL] [Abstract][Full Text] [Related]
4. Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria.
van Roosmalen ML; Kanninga R; El Khattabi M; Neef J; Audouy S; Bosma T; Kuipers A; Post E; Steen A; Kok J; Buist G; Kuipers OP; Robillard G; Leenhouts K
Methods; 2006 Feb; 38(2):144-9. PubMed ID: 16414272
[TBL] [Abstract][Full Text] [Related]
5. DNA vaccines for biodefence.
Garmory HS; Perkins SD; Phillpotts RJ; Titball RW
Adv Drug Deliv Rev; 2005 Jun; 57(9):1343-61. PubMed ID: 15935877
[TBL] [Abstract][Full Text] [Related]
6. Cell surface display system for Lactococcus lactis: a novel development for oral vaccine.
Raha AR; Varma NR; Yusoff K; Ross E; Foo HL
Appl Microbiol Biotechnol; 2005 Jul; 68(1):75-81. PubMed ID: 15635459
[TBL] [Abstract][Full Text] [Related]
7. Mucosal vaccination and therapy with genetically modified lactic acid bacteria.
Wells J
Annu Rev Food Sci Technol; 2011; 2():423-45. PubMed ID: 22129390
[TBL] [Abstract][Full Text] [Related]
8. A food-grade delivery system for Lactococcus lactis and evaluation of inducible gene expression.
Simões-Barbosa A; Abreu H; Silva Neto A; Gruss A; Langella P
Appl Microbiol Biotechnol; 2004 Jul; 65(1):61-7. PubMed ID: 14758518
[TBL] [Abstract][Full Text] [Related]
9. Use of attenuated bacteria as delivery vectors for DNA vaccines.
Daudel D; Weidinger G; Spreng S
Expert Rev Vaccines; 2007 Feb; 6(1):97-110. PubMed ID: 17280482
[TBL] [Abstract][Full Text] [Related]
10. Plasmid Replicons for the Production of Pharmaceutical-Grade pDNA, Proteins and Antigens by
Duarte SOD; Monteiro GA
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573129
[TBL] [Abstract][Full Text] [Related]
11. Display of heterologous proteins on the surface of Lactococcus lactis using the H and W domain of PrtB from Lactobacillus delburueckii subsp. bulgaricus as an anchoring matrix.
Kim TW; Igimi S; Kajikawa A; Kim HY
J Appl Microbiol; 2008 Jun; 104(6):1636-43. PubMed ID: 18298534
[TBL] [Abstract][Full Text] [Related]
12. Recombinant invasive Lactococcus lactis can transfer DNA vaccines either directly to dendritic cells or across an epithelial cell monolayer.
de Azevedo M; Meijerink M; Taverne N; Pereira VB; LeBlanc JG; Azevedo V; Miyoshi A; Langella P; Wells JM; Chatel JM
Vaccine; 2015 Sep; 33(38):4807-12. PubMed ID: 26241952
[TBL] [Abstract][Full Text] [Related]
13. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA
Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
[TBL] [Abstract][Full Text] [Related]
14. Genetic transformation of novel isolates of chicken Lactobacillus bearing probiotic features for expression of heterologous proteins: a tool to develop live oral vaccines.
Mota RM; Moreira JL; Souza MR; Horta MF; Teixeira SM; Neumann E; Nicoli JR; Nunes AC
BMC Biotechnol; 2006 Jan; 6():2. PubMed ID: 16396687
[TBL] [Abstract][Full Text] [Related]
15. Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria.
Cortes-Perez NG; Lefèvre F; Corthier G; Adel-Patient K; Langella P; Bermúdez-Humarán LG
Vaccine; 2007 Sep; 25(36):6581-8. PubMed ID: 17675182
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of Lactococcus lactis delivered heat shock protein 65 attenuates atherosclerosis in low-density lipoprotein receptor-deficient mice.
Jing H; Yong L; Haiyan L; Yanjun M; Yun X; Yu Z; Taiming L; Rongyue C; Liang J; Jie W; Li Z; Jingjing L
Vaccine; 2011 May; 29(24):4102-9. PubMed ID: 21497632
[TBL] [Abstract][Full Text] [Related]
17. Peyer's Patches as a Portal for DNA Delivery by Lactococcus lactis in Vivo.
Yano A; Takahashi K; Mori Y; Watanabe S; Hanamura Y; Sugiyama T; Inoue N
Biol Pharm Bull; 2018; 41(2):190-197. PubMed ID: 29386479
[TBL] [Abstract][Full Text] [Related]
18. Live bacterial delivery systems for development of mucosal vaccines.
Thole JE; van Dalen PJ; Havenith CE; Pouwels PH; Seegers JF; Tielen FD; van der Zee MD; Zegers ND; Shaw M
Curr Opin Mol Ther; 2000 Feb; 2(1):94-9. PubMed ID: 11249657
[TBL] [Abstract][Full Text] [Related]
19. Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV.
Daniel C; Sebbane F; Poiret S; Goudercourt D; Dewulf J; Mullet C; Simonet M; Pot B
Vaccine; 2009 Feb; 27(8):1141-4. PubMed ID: 19135495
[TBL] [Abstract][Full Text] [Related]
20. Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection.
Villena J; Medina M; Raya R; Alvarez S
Can J Microbiol; 2008 Oct; 54(10):845-53. PubMed ID: 18923553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
